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The remaining dosimetric parameters were affected only up 
to 1% by other planning factors except for increasing the 
margin between PTV and multi leaf collimators (MLC) edge 
(range, 1-3 mm) (1-7% difference). The best CI was seen with 
9 static fields compared with DCA regardless of number of 
arcs used (2% difference). CI improved with the following - 
decreasing PTV to MLC margin (up to 10% difference), 
increasing number of static fields (1-2% difference), using 10 
MV FFF (2% difference) and with arc length & table spread for 
irregular shaped targets (1% difference).  
Patient study  
Similar results were obtained with all techniques. Total mean 
number of MUs were 3144, 3166, 3121 for 3DCA, 4DCA and 9 
static fields plans respectively. The mean CI was 2.3, 2.1 and 
2.2 using 3DCA, 4DCA and 9 static field plans respectively. 
The normal tissue mean doses were 1.3% for all three 
techniques.  
 
Conclusion: All evaluated radiosurgical plans were 
acceptable for clinical use. The technique was chosen based 
on delivery efficiency and dose to normal brain. 10 MV FFF 
was more efficient and more conformal. 4DCA delivers lower 
dose to a larger volume of the brain compared to 9 static 
fields which delivers higher dose to a smaller volume. The 
MLC margin is a compromise between CI and doses to the 
PTV. To conclude 4DCA 10MV FFF was chosen for clinical use, 
the MLC margin depends on the target volume. 
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Purpose or Objective: To investigate the feasibility in 
Tomotherapy (HT) of a hypofractionated DP (Dose Painting) 
treatment on GBM (Glioblastoma Multiforme) cancer patients 
using ADC maps derived from DW-MRI. 
 
Material and Methods: Five patients, who underwent GBM 
radiotherapy, were retrospectively considered, prescribing a 
dose escaled from 25 to 50 Gy in 5 fractions. The objective 
was that at least the 95% of the CTV received at least 25 Gy. 
DPBN dose prescription maps were generated from ADC-MRI, 
registered with planning CT, for each patient. The ADC pixel 
values (mm^2/s) within the CTV were converted to dose 
values (Gy) using the equation Eq. 1 where Dmin and Dmax 
are the minimum and maximum total dose of prescription 
(25-50 Gy). Imin and Imax are the minimum and maximum 
significative values of ADC selected on the basis of the ADC 
differential histogram, inside the CTV region. 
Then it was necessary to discretize each DPBN maps in 9 
isodose levels (Deveau et al., Acta Oncol. 2010) in order to 
obtain a corresponding DPBC map. The final DPBC map was 
realized minimizing, with an iterative process, the difference 
between DPBN and DPBC, evaluated by means of Quality 
Factor (QF) (Vanderstraeten et al., Phys. Med. Biol. 2006). 
The QF is, defined as in Eq. 2 and Eq. 3 where i is the i-th 
voxel. Then plans were optimized on a standard HT TPS and a 
TPS Dose Distribution (TDD) was obtained. For each patient 
the TDD was compared with the prescribed DPBN using a Qi 
distribution, defined as the ratio of TDDi and DPBNi. The 
quality of the treatment plans was evaluated in term of QF 
and Q0.9-1.1, that represents the volume of the CTV in which 
the Qi ranges from 0.9 to 1.1. Eventually the delivery of the 
DP plans was assessed with Octavius system (PTW). 
 
 
 
Results: Fig. 1 reports the different distributions obtained for 
Patient 1. 
Tab. 1 shows quantitative DVH and quality analysis of the 
treatment doses for the CTVs, mean values OAR Dmax for all 
five patients, and γ results for the DQA performed. The 
constraints for the OAR were respected in all the five plans 
as well as the coverage of the CTVs with the minimum 
prescribed dose of 25 Gy. The QF ranges from 0.126 to 0.176, 
while the mean value of Q0.9−1.1 was 68% ± 7%. The delivery 
time ranges from a minimum of 38.3 minutes to a maximum 
of 63.6 minutes. All DQA performed are within the 
acceptance criteria with a mean value of γ of 87.4%. 
 
 
 
Conclusion: Our results provides the feasibility of a ADC-
based dose painting treatment in GBM cancer patients, 
respecting dose constraints to OAR and minimum target 
coverage. The plans obtained are deliverable, even if there is 
some concern about the HT delivery time. Clinical studies 
should be conducted to evaluate toxicities and tumor 
response of such a strategy. 
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Purpose or Objective: Management of pelvic sidewall 
recurrence in gynaecological cancer is a challenging clinical 
scenario with only 10-20% 5-year survival. For patients 
previously treated with radiotherapy, salvage surgery has 
high morbidity and outcomes are poor. Recent radiotherapy 
advances including stereotactic radiotherapy provide the 
opportunity for more effective salvage techniques. 
Systematic assessment is required to determine optimal 
treatment approaches.  
The aims of this study were: (1) To determine target and OAR 
dose targets for pelvic re-irradiation (2) To compare ICRU 83 
normalisation and prescription (ICRU) to the stereotactic 
radiosurgery convention of prescribing to a covering isodose 
